American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing.
[2]
World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.
[3]
Goodwin, G.M., et al. (2016). Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30(6), 495-553.
[4]
Yatham, L.N., et al. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97-170.
[5]
Ketter, T.A. (2010). Handbook of Bipolar Disorder: Diagnosis and Therapeutic Approaches. Arlington, VA: American Psychiatric Publishing.
[6]
Muller-Oerlinghausen, B., et al. (2000). The suicide preventive effect of long-term lithium therapy. In: Birch, N.J., et al. (eds.) Lithium: Inorganic Pharmacology and Psychiatric Use. Oxford: IRL Press.
[7]
Geddes, J.R., & Miklowitz, D.J. (2013). Treatment of bipolar disorder. The Lancet, 381(9878), 1672-1682.
[8]
Tohen, M., et al. (2009). Olanzapine plus carbamazepine versus carbamazepine alone in treating bipolar episodes. Archives of General Psychiatry, 66(4), 446-447.